Facial Paralysis in Otitis Media Due to Granulomatosis with Polyangiitis

Madeleine C Chao1, Yalda Yazdani1, Hamid R Djalilian1,2,3

  • 1Division of Otology and Neurotology, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA, USA.

Ear, Nose, & Throat Journal
|September 24, 2024
PubMed

Insights

Facial paralysis can be a rare sign of Granulomatosis with polyangiitis (GPA), a condition often causing ear and respiratory issues. Early diagnosis of GPA is crucial, especially in adults with unexplained otitis media and facial nerve symptoms.

Area of Science:

  • Rheumatology
  • Otolaryngology
  • Neurology

Background:

  • Granulomatosis with polyangiitis (GPA), previously known as Wegener's granulomatosis, is a rare necrotizing vasculitis.
  • GPA typically affects the upper and lower respiratory tracts and can cause otitis media and hearing loss.

Observation:

  • Facial nerve paralysis is an uncommon but significant manifestation of GPA.
  • This report details a case of facial paralysis co-occurring with otitis media, leading to a delayed GPA diagnosis.

Findings:

  • While acute suppurative otitis media is a common cause of facial paralysis, GPA should be considered in specific clinical scenarios.
  • Key indicators for considering GPA include new-onset, painful serous otitis, acute otitis media, or the presence of pale granulation tissue in the middle ear of adults without prior Eustachian tube dysfunction.

Implications:

  • Recognizing GPA in patients presenting with otitis media and facial paralysis is critical for timely diagnosis and treatment.
  • This case highlights the importance of considering systemic vasculitis in the differential diagnosis of otological and neurological symptoms, even when seemingly unrelated causes are apparent.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.4K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
212
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
230
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
695